Site-specific antibody–drug conjugation through glycoengineering

Q Zhou, JE Stefano, C Manning, J Kyazike… - Bioconjugate …, 2014 - ACS Publications
Antibody–drug conjugates (ADCs) have been proven clinically to be more effective anti-
cancer agents than native antibodies. However, the classical conjugation chemistries to …
被引用次数：266 相关文章

Site-specific antibody-drug conjugation through glycoengineering.

Q Zhou, JE Stefano, C Manning, J Kyazike… - Bioconjugate …, 2014 - europepmc.org
Antibody-drug conjugates (ADCs) have been proven clinically to be more effective anti-
cancer agents than native antibodies. However, the classical conjugation chemistries to …

Site-specific antibody-drug conjugation through glycoengineering

C Pan, Q Zhou, J Stefano, P Dhal, B Chen… - 2014 - Google Patents
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …

Site-specific antibody-drug conjugation through glycoengineering

Q Zhou, JE Stefano, C Manning… - Bioconjugate …, 2014 - pubmed.ncbi.nlm.nih.gov
Antibody-drug conjugates (ADCs) have been proven clinically to be more effective anti-
cancer agents than native antibodies. However, the classical conjugation chemistries to …

[引用][C] Site-Specific Antibody–Drug Conjugation through Glycoengineering

Q Zhou, JE Stefano, C Manning, J Kyazike… - Bioconjugate …, 2014 - cir.nii.ac.jp
Site-Specific Antibody–Drug Conjugation through Glycoengineering | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Site-specific antibody-drug conjugation through glycoengineering

C Pan, Q Zhou, J Stefano, P Dhal, B Chen… - 2016 - Google Patents
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …